Skip to content
lifestyle.washingtonguardian.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
ZENTALIS PHARMACEUTICALS
Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates
September 11, 2026
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
September 2, 2026
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 1, 2026
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 17, 2026
Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering
August 13, 2026
Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
August 13, 2026
Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates
August 6, 2026
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 3, 2026
Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
July 17, 2026
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 1, 2026
1
2
Next Page
→